This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $2100 | Check With Us |
200mg | $3150 | Check With Us |
500mg | $5315 | Check With Us |
Cat #: V5224 CAS #: 1952236-05-3 Purity ≥ 98%
Description: MTX-211 is a novel and potent dual inhibitor of EGFR and PI3K with the potential to be used for the treatment of cancer, in particular KRAS mutant colorectal cancer.
References: Small molecule inhibitors of egfr and pi3k. WO 2016100347 A2
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 478.33 |
---|---|
Molecular Formula | C20H14Cl2FN5O2S |
CAS No. | 1952236-05-3 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
SMILES Code | CS(=O)(NC1=CC(C2=CC3=C(NC4=CC=C(F)C(Cl)=C4)N=CN=C3C=C2)=CN=C1Cl)=O |
Synonyms | MTX-211; MTX211; MTX 211 |
Protocol | In Vitro | MTX-211 (MOL211) has inhibitory activity for both EGFR and PI3K Alpha with IC50 values of <100 nM. |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.0906 mL | 10.4530 mL | 20.9061 mL | 41.8121 mL |
5mM | 0.4181 mL | 2.0906 mL | 4.1812 mL | 8.3624 mL |
10mM | 0.2091 mL | 1.0453 mL | 2.0906 mL | 4.1812 mL |
20mM | 0.1045 mL | 0.5227 mL | 1.0453 mL | 2.0906 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.